Celltrion Healthcare Co Ltd
KOSDAQ:091990

Watchlist Manager
Celltrion Healthcare Co Ltd Logo
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Watchlist
Price: 75 900 KRW -5.6% Market Closed
Market Cap: 12.5T KRW
Have any thoughts about
Celltrion Healthcare Co Ltd?
Write Note
Celltrion Healthcare Co Ltd
/
Cash Flow Statement
/
Cash from Investing Activities

Celltrion Healthcare Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celltrion Healthcare Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Cash from Investing Activities
₩137.4B
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Chorokbaem Healthcare Co Ltd
KRX:118000
Cash from Investing Activities
₩8.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WSI Co Ltd
KOSDAQ:299170
Cash from Investing Activities
-₩8.3B
CAGR 3-Years
-134%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
W
Wonik Co Ltd
KOSDAQ:032940
Cash from Investing Activities
-₩2.9B
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HLB Life Science Co Ltd
KOSDAQ:067630
Cash from Investing Activities
-₩26.1B
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
-37%
B
BlueMTec Co Ltd
KOSDAQ:439580
Cash from Investing Activities
-₩23.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Celltrion Healthcare Co Ltd
Glance View

Market Cap
12.2T KRW
Industry
Health Care

Celltrion Healthcare Co Ltd has carved a distinctive niche in the competitive biotechnology landscape by capitalizing on its expertise in biosimilars, which are biopharmaceutical drugs almost identical to original products. The company's origins trace back to a broader vision of democratizing healthcare, striving to make biologic treatments more accessible and affordable worldwide. With its roots in South Korea, Celltrion Healthcare, a subsidiary of Celltrion Inc., has harnessed cutting-edge technology to replicate complex biological drugs. These drugs, usually utilized for chronic conditions such as autoimmune diseases and cancer, are pivotal in offering alternatives to high-cost branded biologics. By focusing on biosimilars, Celltrion addresses both a global healthcare cost crisis and a burgeoning demand for effective therapies as aging populations grow. The business model revolves around developing, manufacturing, and distributing these biosimilars. Celltrion Healthcare primarily benefits from the lower production costs compared to innovator biologics and the subsequent market penetration achieved through competitive pricing. They have established an extensive global distribution network, which enhances their reach. Collaborations with various international partners bolster their presence in strategic markets, allowing comprehensive coverage across multiple continents. Revenue is generated from licensing agreements, direct sales, and strategic partnerships, ensuring a diversified income stream. In parallel, the company's vigorous pipeline of new products promises sustained growth, aimed at expanding their therapeutic portfolio while leveraging their expertise to outpace competitors in this burgeoning field.

Intrinsic Value
64 511.48 KRW
Overvaluation 15%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Celltrion Healthcare Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
137.4B KRW

Based on the financial report for Jun 30, 2023, Celltrion Healthcare Co Ltd's Cash from Investing Activities amounts to 137.4B KRW.

What is Celltrion Healthcare Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-1%

The average annual Cash from Investing Activities growth rates for Celltrion Healthcare Co Ltd have been -1% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 216,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.